Cadila Health Q2 cons net profit down 41% at Rs 100 cr

7126 Investors following Cadila Health. Share this News with them.

0

Like this story, share it with millions of investors on M3

Cadila Health Q2 cons net profit down 41% at Rs 100 cr

Cadila Healthcare has reported a consolidated net profit of Rs 100 crore in the second quarter of FY12, a massive fall of 41.2% as compared to Rs 170 crore in the corresponding quarter of last fiscal.

Post your opinion here

 

0

Tweet

Share on Tumblr

ALSO READ News and Notices about Cadila Health See interviews with Cadila Health Management See what other Experts & Brokerages are saying about Cadila Health See previous Results of Cadila Health

Cadila Healthcare has reported a consolidated net profit of Rs 100 crore in the second quarter of FY12, a massive fall of 41.2% as compared to Rs 170 crore in the corresponding quarter of last fiscal.

Consolidated net sales jumped 10% to Rs 1,220 crore from Rs 1,110 crore during the same period.

In the July-September quarter,

* Zydus Cadila acquired German company, Bremer Pharma GmbH, from ICICI Venture, gaining global footprint in animal healthcare business

* The manufacturing plant of the company at Baddi, Himachal Pradesh has received approval from USFDA.